Semax is a synthetic peptide developed in Russia from a fragment of ACTH, originally researched for neuroprotective and cognitive effects. It is commonly studied for its potential to increase brain-derived neurotrophic factor (BDNF), support dopamine and serotonin signaling, reduce inflammation, and improve recovery after brain stress or injury. In Russia and some Eastern European countries, Semax has been used clinically for ischemic stroke, cognitive impairment, traumatic brain injury, optic nerve disorders, and attention or memory problems. Researchers are also investigating its possible role in neuroplasticity, mood support, learning, focus, and protection against oxidative stress and hypoxia in experimental settings worldwide
Semax (10mg)
$45.00
